The level of MCM3AP-AS1 was positively associated with estrogen receptor (ER) and progesterone receptor (PR) expression, whereas no significant differences were observed between MCM3AP-AS1 and HER2 expression profiles in breast cancer patients. Here, PGR is linked to breast cancer.